Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer

Both weekly cisplatin chemotherapy and single agent topotecan have proven to be effective in recurrent ovarian cancer. Preclinical data show synergism between cisplatin and topotecan. Side effects for this combination are drug sequence dependent and predominantly haematologic. Since preclinical data...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelderblom, H, Sparreboom, A, Jonge, M J A de, Loos, W J, Wilms, E, Mantel, M A, Hennis, B, Camlett, I, Verweij, J, Burg, M E L van der
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375148/
https://www.ncbi.nlm.nih.gov/pubmed/11710824
http://dx.doi.org/10.1054/bjoc.2001.2014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375148/
https://www.ncbi.nlm.nih.gov/pubmed/11710824
http://dx.doi.org/10.1054/bjoc.2001.2014

Ejemplares similares